USPTO trademark

NURVEXXY

Awaiting publicationUSPTOWord markClass 5

"NURVEXXY" is a word mark owned by Sanofi, filed at the USPTO on August 12, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).

View Sanofi portfolioGet this data via the API
Official USPTO record
NURVEXXY trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 14, 2026
Filed
August 12, 2026
Registered
Not yet
Priority date
February 16, 2026
Claimed from France
Application no.
50045886
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns NURVEXXY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Sanofi

Paris, France

3,998 trademarks in the portfolioView company

Representative

Alexandra Kochian

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services NURVEXXY is filed for, grouped by Nice class.

  • (Based on 44(e)) (Based on Intent to Use) Pharmaceutical preparations for the treatment and prevention of immunological, immune, inflammatory, respiratory and hepatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare immunological diseases, diseases related to the immune system, immune, inflammatory, respiratory and hepatological diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Notification of examiners amendment e-mailed
  3. Examiner's amendment entered
  4. Examiners amendment e-mailed
  5. Examiners amendment -written
  6. Assigned to examiner
  7. Teas amendment entered before attorney assigned
  8. Teas voluntary amendment received
  9. Application filing receipt mailed
  10. New application office supplied data entered

1 earlier step on the official record.

FAQ

About NURVEXXY

Who owns the trademark "NURVEXXY"?

The USPTO trademark "NURVEXXY" (application 50045886) is owned by Sanofi.

What is the status of "NURVEXXY"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NURVEXXY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019ffb48-6c3e-7107-9cfe-2a4977994d0c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019ffb48-6c3e-7107-9cfe-2a4977994d0c",
  "object": "trademark",
  "mark_text": "NURVEXXY",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "50045886",
  "filing_date": "2026-08-12",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Sanofi",
      "entity_id": "ent_019eb6f6-62f9-773d-a835-46d137e82556"
    }
  ]
}